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Abstract
Background: Diabetes has become the single most common cause for end-stage renal disease in
the United States. It has been established that mitochondrial damage occurs during diabetes;
however, little is known about what initiates mitochondrial injury and oxidant production during
the early stages of diabetes. Inactivation of mitochondrial respiratory complexes or alteration of
their critical subunits can lead to generation of mitochondrial oxidants, mitochondrial damage, and
organ injury. Thus, one goal of this study was to determine the status of mitochondrial respiratory
complexes in the rat kidney during the early stages of diabetes (5-weeks post streptozotocin
injection).
Methods: Mitochondrial complex activity assays, blue native gel electrophoresis (BN-PAGE),
Complex III immunoprecipitation, and an ATP assay were performed to examine the effects of
diabetes on the status of respiratory complexes and energy levels in renal mitochondria. Creatinine
clearance and urine albumin excretion were measured to assess the status of renal function in our
model.
Results: Interestingly, of all four respiratory complexes only cytochrome c reductase (Complex-
III) activity was significantly decreased, whereas two Complex III subunits, Core 2 protein and
Rieske protein, were up regulated in the diabetic renal mitochondria. The BN-PAGE data suggested
that Complex III failed to assemble correctly, which could also explain the compensatory
upregulation of specific Complex III subunits. In addition, the renal F0F1-ATPase activity and ATP
levels were increased during diabetes.
Conclusion: In summary, these findings show for the first time that early (and selective)
inactivation of Complex-III may contribute to the mitochondrial oxidant production which occurs
in the early stages of diabetes.
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Background
Renal dysfunction is a major complication that affects 20–
40% of individuals with diabetes [1] and diabetic neph-
ropathy is the most common cause of end stage renal dis-
ease (ESRD) in the United States [2]. Currently, no
treatment options are available to prevent the renal com-
plications of diabetes except for therapies which may slow
the progression through intensive control of blood glu-
cose and blood pressure [3]. Thus, it is important to iden-
tify new therapeutic targets that might lead to the
prevention of diabetes-induced nephropathy.
Several reports indicate that hyperglycemia-induced gen-
eration of superoxide within the mitochondria plays a
major role in the development of diabetic complications
[4-7]. Nevertheless, the role that hyperglycemia has on
renal mitochondrial respiratory complex function has not
been thoroughly investigated. A few studies have indi-
cated that diabetes induces alterations in the activities of
mitochondrial respiratory complexes and mitochondrial
respiration in the kidney [8,9]. Rosca et al. demonstrated
that renal Complex-III was a target for glycation and inhi-
bition during chronic diabetes (12 months) [8]. A study
by Katyare and Satav showed that respiration rates and
ATPase activity were elevated in diabetic renal mitochon-
dria. This study also demonstrated that renal mitochon-
dria were tightly coupled during diabetes [9]. In addition,
Complex-III has also been shown to be inhibited during
chronic diabetes in diabetic mouse retina [10]. Among the
four respiratory complexes I through IV that comprise the
electron transport chain, Complex-I and III are thought to
be the major sources for superoxide generation within the
mitochondria [11]. However, the effect that short-term
hyperglycemia has on renal mitochondrial complexes has
not been examined in detail, and may lead to a more pre-
cise understanding of the initiating events involved with
mitochondrial oxidant production during diabetes.
In this study, we have examined the status of renal mito-
chondrial complexes during the early stages (5-weeks) of
experimental Type-1 diabetes using the streptozotocin-
induced diabetes rat model. Our findings provide evi-
dence for the first time that short-term diabetes caused
selective Complex-III inactivation (with no effect on
Complex I, II, or IV). In addition, further studies indicated
that two Complex III subunits were induced following
diabetes. These results suggest that in the early stages of
hyperglycemia Complex III has assembly defects which
could cause oxidant generation, leading to impairment of
mitochondrial and renal function during hyperglycemia.
Methods
Streptozotocin-induced diabetes model
Male Sprague Dawley rats weighing 200 ± 50 g obtained
from Harlan Sprague Dawley Inc. were used for this study.
All of the animal protocols were approved by the Institu-
tional Animal Care and Use Committee at the University
of Arkansas for Medical Sciences to perform as described
in the paper. Rats were randomly divided into two groups:
control and diabetic. Diabetes was induced by injecting
overnight fasted rats with streptozotocin (STZ; 65 mg/kg,
i.p.) dissolved in 0.5 ml saline, while the control rats were
injected with 0.5 ml saline. Fasting blood glucose levels
were measured 48 hours post-STZ injection and rats with
blood glucose levels greater than 250 mg/dl were classi-
fied as "diabetic". Diabetes-induced changes were studied
at 5 weeks post-STZ injection (n = 6).
Metabolic studies, organ harvest and blood collection
Animals were kept in metabolic cages and acclimatized
overnight prior to urine collection. Urine was collected
from each rat for 24 hr, and their 24 hr food and water
intake were also measured. Animals were sacrificed under
isoflurane anesthesia and their kidneys harvested. Blood
was collected via intracardiac puncture and serum sam-
ples were stored at -80°C until used for creatinine meas-
urement.
Creatinine clearance & urine albumin measurement
Serum creatinine (sCr) and urine creatinine (uCr) levels
were measured by a modified Jaffe's method (Pointe Sci-
entific, Canton, MI, USA) in a Cobas Mira clinical ana-
lyzer (Roche Diagnostics, Indianapolis, IN, USA).
Creatinine clearance (CrCl) was then calculated from the
formula: CrCl (ml/min/kg) = (uCr × uVolume × Body
weight)/(sCr × 1440 min × 1000). Urine albumin levels
were determined by an immunoturbidometric assay
(Pointe Scientific, Canton, MI, USA) in a Cobas Mira clin-
ical analyzer and expressed as mg/day/kg.
Histological scoring
Periodic acid-Schiff (PAS) staining was performed on for-
malin fixed, paraffin embedded kidney sections to assess
tubular integrity and renal morphology as previously
described [12,13]. Tissue sections were scored on a 0 to 4
scale by two pathologists blinded to the treatment groups
according to the extent of tubular dilation and glomerular
changes as follows: 0 = absent; 1 = mild; 2 = moderate; 3
= severe; 4 = very severe.
Measurement of respiratory complex activities
Renal mitochondria were isolated from whole kidneys by
differential centrifugation in a sucrose-containing buffer
as previously described [14,15]. The activity of mitochon-
drial Complexes-I through IV as described by Birch-
Machin et al. [16] with minor modifications as previously
described [15].
FoF1-ATP-ase (Complex-V) activity was assayed by meas-
uring the release of Pi from ATP by the method of Law et
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al.[17]. Each sample was run in the presence and absence
of oligomycin (10 μg/ml), and the FoF1-ATP-ase activity
was expressed as the oligomycin-sensitive ATPase activity.
Blue Native Gel Electrophoresis (BN-PAGE)
Mitochondrial complexes were analyzed by performing
BN-PAGE on the control and diabetic mitochondria as
previously described [15]. To confirm the identity of
mitochondrial Complex-III following BN-PAGE, the
native gel was directly transferred to a PVDF membrane
after first dimension and probed for known Complex III
subunits Core 2 and Rieske subunits as described below.
In addition, immunoblot analysis for Rieske and Core 2
subunits was performed following two-dimensional BN-
PAGE by performing BN-PAGE, excising the Complex III
bands, followed by SDS-PAGE in the second dimension.
ATP Assay
ATP levels were determined in the mitochondrial fractions
of control and diabetic rat kidneys using a luciferase based
bioluminescent assay kit (Sigma-Aldrich, St. Louis, MO,
USA) in a TD 20/20 luminometer (Turner Designs, Sun-
nyvale, CA, USA).
Immunoprecipitation of Complex-III
Complex-III was immunoprecipitated from control and
diabetic rat renal mitochondria (2.5 mg) as described by
Shilling et al. [18] using Complex-III immunocapture
beads (MS301) from Mitosciences, USA. After SDS-PAGE,
the gels were stained with Coomassie blue staining solu-
tion (0.1% bromophenol blue R-250 in 40% methanol
and 10% acetic acid) for 30 minutes and then destained
overnight in 7.5% acetic acid/5% methanol solution.
For immunoblotting, the gel was transferred to a PVDF
membrane, and probed for Core 2 protein or the Rieske
subunit using mouse monoclonal antibodies – MS304 or
MS305 (Mitosciences) at 1:1,000 dilution overnight at
4°C. Blots were then probed with peroxidase labeled goat
anti-mouse secondary antibody, and developed using an
enhanced chemiluminescent substrate system.
Statistical Analysis
Data analysis was performed using Origin 6.0. All values
were expressed as mean ± SEM. Independent t-test (two-
tailed) was used to compare the mean values between
control and diabetic groups. Differences were considered
statistically significant if the p values were less than 0.05.
Results
Diabetic Rat Model
Rats made diabetic with STZ had fasting blood glucose
levels of ~350 mg/dl, 48 hours after injection. Consistent
with numerous reports, our diabetic rats (5-weeks post-
STZ) showed a significant elevation in fasting blood glu-
cose, 480.0 ± 69.3 mg/dl Vs 66.3 ± 3.8 mg/dl in an age-
matched control group.
Diabetic rats also exhibited the typical hallmark features
of diabetes: polyuria, polydipsia, polyphagia, and a signif-
icant decrease in body weight compared to the control
group (Table 1).
Diabetes induces hyperfiltration, albuminuria, and renal 
damage
Creatinine clearance, a measure of glomerular filtration
rate, was used to monitor kidney function, and urinary
albumin excretion was used as a marker for early develop-
ment of renal injury in our diabetic rat model. A signifi-
cant elevation in creatinine clearance was observed in the
diabetic group (6.53 ± 0.36 ml/min/kg) compared to the
age-matched control group (4.80 ± 0.42 ml/min/kg),
indicating STZ-induced diabetes caused hyperfiltration in
the kidney (Figure 1A). In addition, STZ-injected rats also
showed a significant increase in urinary albumin excre-
tion (8.43 ± 1.74 mg/day/kg in diabetic group Vs 0.9 ±
0.03 mg/day/kg in age-matched controls) (Figure 1B).
Periodic Acid-Schiff (PAS) staining (which stains carbohy-
drates in brush borders, tubules, and glomerular base-
ment membrane) was used to assess renal damage in the
diabetic rat kidneys. Histological scoring of PAS stained
kidney sections by two pathologists revealed that diabetes
caused a moderate renal damage (a score of 0.17 in con-
trol Vs 2.0 in diabetic group) (Figure 1C).
Hyperglycemia induces specific alterations to renal 
mitochondrial respiratory complexes
To examine whether early diabetes had a significant
impact on the renal mitochondrial respiratory chain, we
used a relatively novel technique called Blue Native-Poly-
acrylamide Gel Electrophoresis (BN-PAGE). BN-PAGE
Table 1: Metabolic effects of STZ-induced diabetes in rats.
Parameters Control Diabetic
Fasting blood glucose (mg/dl) 66.3 ± 3.8 480.0 ± 69.3*
Body weight (BW) (g) 371 ± 9.5 260.6 ± 17.6*
Food Intake (g/100 g BW) 5.7 ± 0.3 14.3 ± 0.4*
Water Intake (ml/100 g BW) 9.4 ± 1.7 73.2 ± 3.1*
Urine Output (ml/100 g BW) 3.4 ± 0.3 52.1 ± 2.9*
This table shows the effect of STZ-induced diabetes (5-week post-
STZ) on fasting blood glucose, food intake, water intake, and urine 
output in male Sprague-Dawley rats. All values are expressed as Mean 
± SEM (n = 6). * P < 0.05 compared with age-matched (5-week) 
controls.
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directly detects the membrane bound mitochondrial res-
piratory complexes and, thus, can pinpoint which of the
five respiratory complexes (I-V) show the most intense
change in levels and assembly during diabetes [19].
The BN-PAGE data indicated that Complex-III was
decreased (77.8% of control) and Complex-V was
increased in the diabetic kidneys compared to the control
group (Figure 2A and 2B). In addition to BN-PAGE, respi-
ratory complex activity assays were performed which fur-
ther confirmed that Complex-III activity was significantly
reduced in diabetic renal mitochondria (66.32 ± 1.93%)
as compared to the age-matched controls (100 ± 3.58%,
Figure 2C); while F0F1-ATPase (Complex-V) activity was
increased (148.71 ± 6.45% in diabetic Vs 100 ± 3.37% in
control; Figure 2D). Consistent with increased F0F1-
ATPase activity, ATP levels were also significantly
increased in diabetic rat kidneys (143.39 ± 11.56%) com-
pared to the age-matched controls (100 ± 2.01%; Figure
2E). Interestingly, no significant changes were observed in
the activities of Complexes I, II and IV between the dia-
betic and control groups (Figure 2F–H). It is important to
realize that Complex III contains 11 subunits. Hence, fur-
ther studies were performed to identify the specific subu-
nits within Complex-III that might be altered during
hyperglycemia using Complex III immunoprecipitation.
Surprisingly, Complex III immunoprecipitation in the
diabetic samples yielded more proteins associated with
Complex III when compared to control samples as visual-
ized by Coomassie staining (Figure 3A). The precise rea-
son for the enhanced protein staining in the diabetic
Diabetes-induced renal dysfunctionFigure 1
Diabetes-induced renal dysfunction. Effect of STZ-induced diabetes (5-week post-STZ) on, A) Creatinine clearance, and 
B) Urinary albumin excretion in male Sprague-Dawley rats. Values are expressed as Mean ± SEM (n = 6). * P < 0.05 compared 
with age-matched (5-week) controls. C) Periodic acid-Schiff (PAS) stained sections of control and (5-week post-STZ) diabetic 
rat kidneys observed under 400× magnification. Arrows indicate regions of renal damage. Experiments were repeated three 
times with similar results.
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mitochondria remains unclear, but may be related to
altered assembly of Complex III. Nevertheless, we chose
to focus on the key redox sensitive subunit within Com-
plex III, the Rieske protein as well as the Core 2 protein, a
subunit that is not directly involved with electron transfer.
Thus, Western blot analysis was performed for Rieske or
Core 2 protein following Complex III immunoprecipita-
tion. Diabetes appeared to increase Complex III associ-
ated Rieske and Core 2 proteins when compared to
control kidneys (Figure 3B and 3C). The increased expres-
sion of specific Complex III subunits was further con-
firmed by Western blot analysis using renal mitochondria
(without immunoprecipitation) which also showed an
upregulation of the Complex-III subunits, Rieske (133.33
± 3.1%) and Core 2 protein (136.69 ± 1.44%) during dia-
betes (Figure 3D and 3E) as compared to control. GAPDH
was used as the loading control.
Additional experiments were carried out to verify the
identity of Complex III following BN-PAGE. These
included Western blotting for Rieske and Core 2 proteins
after BN-PAGE (Figure 4A &4B) as well as BN-PAGE fol-
lowed by SDS-PAGE in the second dimension (2D BN-
Diabetes-induced alterations in the activity of mitochondrial complexes and ATP levelsFigure 2
Diabetes-induced alterations in the activity of mitochondrial complexes and ATP levels. A) Blue Native Gel Elec-
trophoresis (BN-PAGE) showing alterations in mitochondrial complex proteins during diabetes. The box represents Com-
plexes-III and V that differ in control and diabetic (5-week post-STZ) mitochondria. B) Densitometric analysis of BN-PAGE 
showing a decrease in Complex III levels during diabetes. (C-H) Bar graphs indicating inactivation of mitochondrial Complex-
III (C), and induction of F0, F1-ATPase (Complex-V) activity (D), and ATP levels (E) in diabetic rat kidney as compared to con-
trols. Activities of renal mitochondrial complexes: F) Complex-I, G) Complex-II, and H) Complex-IV, were not altered by dia-
betes. All values are expressed as percentage Mean ± SEM (n = 5) of controls (set to 100). * P < 0.05 compared with age-
matched controls.
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PAGE) (Figure 4C &4D). These data clearly demonstrated
that the band identified as Complex III in the BN-PAGE
contains both the Rieske and Core 2 subunits of Complex
III.
Discussion
These results indicate that renal Complex-III appears to be
an early and specific mitochondrial target during experi-
mental type-1 diabetes. Complex-III is centrally located in
the electron transfer process and has been implicated as
one of the major sites for superoxide generation in the
mitochondria during diabetes [8,10]. Partial inhibition of
Complex-III during conditions of increased respiration
[9] would decrease the transfer of electrons from ubiqui-
nol to Complex-III, and increase the half-life of ubisemi-
quinone, which leads to generation of superoxide [8,10].
Intriguingly, our results indicated an upregulation of renal
Complex-III subunits, Core 2 and Rieske protein during
diabetes. However, using BN-PAGE it was shown that
Complex III was not correctly assembled (decreased levels
on BN-PAGE) which also correlated with a decrease in
Complex-III activity. Thus, the paradoxical increase in
expression of individual subunits, Core 2 and Rieske pro-
teins could be a compensatory response to restore the
activity of Complex-III during diabetes.
Diabetes-induced upregulation of renal Complex-III subunits, Rieske protein and Core 2 proteinFigure 3
Diabetes-induced upregulation of renal Complex-III subunits, Rieske protein and Core 2 protein. A) Coomassie 
blue stained SDS-Polyacrylamide gel (following immunoprecipitation of Complex-III in control (C) and diabetic (D) rat kidney 
mitochondria) revealing upregulation of mitochondrial Complex-III subunit proteins during diabetes. B) Complex III IP fol-
lowed by Western blot analysis revealed upregulation of Complex III associated Rieske Protein and Core 2 Protein subunits 
during diabetes. C) Densitometric analysis showing Complex III associated subunits were upregulated during diabetes. D) 
Rieske Protein and Core 2 Protein Western blot analysis of total mitochondria. GAPDH Western blot analysis was used as a 
loading control. E) Densitometric analysis of the Western blot shown in panel D. Blots are representative of three separate 
experiments.
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Rieske subunit is a nuclear encoded protein that is
imported into the mitochondrial matrix where it under-
goes a two-step cleavage of its pre-sequence and is translo-
cated into the inner mitochondrial membrane. It has an
iron-sulfur [2Fe-2S] redox center that centrally partici-
pates in the Q cycle by transferring an electron from ubiq-
uinol to cytochrome c1, which then donates it to
cytochrome c. Core 2 subunit, which is also a nuclear
encoded protein is a homolog of mitochondrial process-
ing protease-alpha subunit and is thought to be important
for mitochondrial protein import, processing and integ-
rity of Complex-III [20]. Although, Core 2 subunit is not
primarily involved in electron transfer, genetic deletion of
Core 2 has been shown to affect the assembly of Complex-
III [21]. Thus, an increase in the Rieske as well as the Core
2 subunits suggests a possible assembly defect in Com-
plex-III.
To our knowledge, this is the first report demonstrating
that renal Complex-III and its subunits are altered in the
early stages of diabetes. A study by Rosca et al. showed
previously that Complex-III was a target for glycation by
methyl glyoxal and inactivated during chronic diabetes
(12 months) [8], while no significant changes were
reported at 2 months of diabetes. Although, the reason for
this discrepancy remains unknown; one difference could
be the fraction of the kidney analyzed in the two studies.
Our study utilized whole rat kidneys, whereas the study by
Rosca et al. used the cortical fractions of kidneys.
Although the renal cortex has been primarily considered
to be the energetically active segment of the nephron, sev-
eral studies suggest that the medullary thick ascending
limb (mTAL) is an active site for reabsorption in kidney
and thus might play a major role in mitochondrial super-
oxide production. In addition, increased oxidant produc-
tion has been observed in both the cortical and medullar
regions of the kidney. Thus, we felt it was important to
include both cortex and medulla (whole kidney) for mito-
chondrial isolation and study the net effect of diabetes on
the renal mitochondria.
Despite the findings by Katyare and Satav [9] who showed
increased cytochrome aa3 contents in renal mitochondria
during diabetes, we did not detect any significant changes
in Complex IV activity in our rat model of diabetes. It is
also important to note that the authors could not correlate
the changes in cytochrome content with the altered respi-
ration rates observed during diabetes. In addition, these
Identification of renal Complex-III following BN-PAGEFigure 4
Identification of renal Complex-III following BN-PAGE. Western blot analysis for Rieske Protein (A and C) and Core 
2 Protein (B and D) to confirm the identity of the Complex-III band after one dimension BN-PAGE (left panel/A and B) and 
2D-BN-PAGE (right panel/C and D) using control (C) and diabetic (D) rat kidney mitochondria.
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authors did not measure Complex IV activity and we did
not measure cytochrome aa3 contents so a direct compar-
ison of these studies is difficult to assess. Again, one
important difference between the two studies is the source
of renal mitochondria used: we used whole kidney mito-
chondria, while Katyare and Satav used cortical mitochon-
dria as discussed above.
Our results also showed that F0F1-ATPase activity and
renal ATP levels were significantly increased in the dia-
betic renal mitochondria compared to controls. Interest-
ingly, the study by Katyare and Satav [9] also
demonstrated that respiration and ATPase activity were
increased in diabetic renal mitochondria. Thus, it is possi-
ble that the increased respiration leads to increased pro-
ton motive force (hyperpolarization) and increased ATP
levels which serve to fulfill the increased energy demands
of the kidney during diabetes. Concomitantly, the
increased respiration would likely result in more superox-
ide (oxidant) generation which could lead to alterations
in Complex III. In fact, we have observed that renal prox-
imal tubule cells exposed to hyperglycemia (25 mM; 48
hr) results in mitochondrial hyperpolarization, Complex-
III inhibition, and oxidant production (manuscript under
review).
Conclusion
In conclusion, we have demonstrated that early stages of
diabetes induced alterations in Complex-III, increased
ATP synthase activity, and renal dysfunction. These diabe-
tes-induced alterations in activities of mitochondrial com-
plexes and energy status could contribute to the
underlying role of oxidative stress in the pathogenesis of
diabetic nephropathy. Our future in vitro studies will
explore the mechanistic pathways by which hyperglyc-
emia induces mitochondrial complex dysfunction and
oxidant production. Finally, strategies to limit the extent
of renal mitochondrial damage during hyperglycemia (by
therapeutic agents that will specifically modulate mito-
chondrial function) might prevent or inhibit the develop-
ment of nephropathy in the diabetic population.
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